Table 1 Main characteristics of the eligible studies.

From: Meta analysis: HPV and p16 pattern determines survival in patients with HNSCC and identifies potential new biologic subtype

 

Study [Year]

Time interval of collected data

Total

Men/ women

UICC stage

Localization

HPV subtypes

Mean age [Year]

1

Wittekindt C23

34

25/9

I-IV

OPSCC

16, 33

61

2

Smith EM24

1994–2004

301

188/113

I-IV

all

16, 33, 18

 

3

Kong CS25

99

69/13

II-IV

all

16, 18, 33

 

4

Weinberger PM26

1980–1999 (Yale), 2004–2007 (Georgia)

140

106/34

I-IV

all

16, 18

60.3

5

Heath S27

2004–2007

83

48/35

I-IV

all

HPV16

64

6

Park WS28

2002–2007

93

80/13

I-IV

OPSCC

16, 18, 33

62.1

7

Holzinger D29

1990–2008

199

146/50

I-IV

OPSCC

16, 18, 33, 35

57

8

Liang C30

1999–2003

844

 

I-IV

all

16

 

9

Park K31

2000–2008

142

73/6

III-IV

OPSCC

 

54

10

Evans M32

2001–2006

147

104/34

I-IV

all

16, 18, 33, 56

58.1

11

Stephen JK34

1986–2003

80

66/14

I-IV

all

16

 

12

Rietbergen MM35

2000–2006

841

 

I-IV

OPSCC

16, 35, 33, 18, 45, 58

 

13

Huang H, 201336

1999–2009

66

 

I-IV

OPSCC

16,33,11,35,52,54,58

59

14

Semrau R41

2000–2008

52

42/10

III-IV

OPSCC

16, 18, 33, 35

56.3

15

Melkane AE33

2007–2009

133

94/39

I-IV

OPSCC

16, 18, 33

59

16

Salazar CR37

158

110/43

I-IV

OPSCC

16

 

17

Heiduschka G39

2002–2013

103

46/17

II-IV

OPSCC

 

60.5

18

Chung CH40

683

 

III-IV

all non-OPSCC

 

58

19

Ramshankar V42

1995–2007

167

108/48

I-II

HNSCC

16

 

20

Xu Y38

2004–2013

278

229/27

I-IV

all

11, 16, 33

 

21

Liu JC43

1990–2010

44

30/14

I-IV

OPSCC

16, 35

64

22

Saito Y44

2004–2012

167

130/20

I-IV

all

 

64

23

Descamps G45

 

218

173/45

II-IV

HNSCC

  

24

Mazul AL46

2002–2006

238

 

I-IV

OPSCC

6,11,16,18, 26,31,33,35,39,58,59,82

 

25

Gronhoj Larsen C47

2000–2014

1542

 

I-IV

OPSCC

  
  1. Footnotes: ICC, Yale, Georgia.
  2. Abbreviations: Union for International Cancer Control, UICC; oropharyngeal squamous cell carcinoma, OPSCC; human papillomavirus, HPV.